Liver Cancer Clinical Trials in Massachusetts

36 recruiting studies across 1 city

Browse by City

All Trials in Massachusetts

Phase

Trial	Phase	Sponsor	Dist.
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment	—	Fresenius Kabi	<1 mi
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI	N/A	VA Office of Research and Development	<1 mi
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)	—	HistoSonics, Inc.	<1 mi
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial	Phase 3	NRG Oncology	<1 mi
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer	Phase 2	AstraZeneca	<1 mi
Observational Study Protocol: LIVER-R	—	AstraZeneca	<1 mi
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies	Phase 1	SEED Therapeutics, Inc.	<1 mi
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors	Phase 1/2	Children's Oncology Group	<1 mi
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations	Phase 2	Fore Biotherapeutics	<1 mi
SIRT With Tremelimumab and Durvalumab for Resectable HCC	Phase 1	Jiping Wang, MD, PhD	<1 mi
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma	Phase 1/2	Eureka Therapeutics Inc.	<1 mi
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors	Phase 1/2	ModeX Therapeutics, An OPKO Health Company	<1 mi
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors	Phase 1	Exelixis	<1 mi
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma	Phase 2	Allison O'Neill, MD	<1 mi
Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery	Phase 2	National Cancer Institute (NCI)	<1 mi
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer	—	Dana-Farber Cancer Institute	<1 mi
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors	Phase 1/2	Tango Therapeutics, Inc.	<1 mi
National Liver Cancer Screening Trial	Phase 4	University of Texas Southwestern Medical Center	<1 mi
Psychoeducational Intervention for Patients With Hepatocellular Carcinoma	N/A	Massachusetts General Hospital	<1 mi
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors	Phase 1/2	DualityBio Inc.	<1 mi
Stereotactic Magnetic Resonance Guided Radiation Therapy	N/A	Dana-Farber Cancer Institute	<1 mi
FOG-001 in Locally Advanced or Metastatic Solid Tumors	Phase 1/2	Parabilis Medicines, Inc.	<1 mi
Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases	Early 1	Dana-Farber Cancer Institute	<1 mi
Jump: MR Simulation For Radiation Therapy Master Protocol	N/A	Brigham and Women's Hospital	<1 mi
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy	Phase 3	Pierre Fabre Medicament	<1 mi
COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER	Phase 1/2	Massachusetts General Hospital	<1 mi
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years	Phase 4	Guerbet	<1 mi
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations	Phase 1	Tyra Biosciences, Inc	<1 mi
Distance-Based Exercise to Preserve Function and Prevent Disability	N/A	Alliance for Clinical Trials in Oncology	<1 mi
Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver	N/A	Massachusetts General Hospital	<1 mi
Computer Guided Microwave Liver Ablation	N/A	NE Scientific INC	<1 mi
Botensilimab, Balstilimab, and SBRT in Colorectal Cancer	Early 1	Massachusetts General Hospital	<1 mi
Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis	—	Massachusetts General Hospital	1 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry	—	Massive Bio, Inc.	39 mi
Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC	Phase 2	Brown University	41 mi
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy	Phase 1/2	7 Hills Pharma, LLC	41 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.